Clinical trials point to GLP-1 drugs possibly helping with alcohol, opioid and nicotine addiction by changing how the brain responds, per U.S. News.
Recap by typeshit. Post by U.S. News Health on X.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The pill is nearing a regulatory decision in Australia, and the report puts the number of Australians tied to the story at over 10,000.
Speaking to People, she also recalls asking her dad Ozzy for help while she was struggling. The interview has the rest.
Loading…